INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 217S · 10 late217 trades$54.77M
  2. 02SPSaba Capital Management, L.P.55B / 21S · 3 late76 trades$25.87M
  3. 03ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  4. 04AJAllaire Jeremy0B / 50S50 trades$4.26M
  5. 05CFCheng Chi Fung0B / 42S42 trades$15.33M
  6. 06RARothblatt Martine A0B / 33S33 trades$5.50M
  7. 07RJRubinstein Julie0B / 32S32 trades$5.55M
  8. 08LBLeach Bryan0B / 30S30 trades$7.97M
  9. 09AOAtay Oguzhan0B / 30S30 trades$7.55M
  10. 10JDJenkins William D Jr0B / 30S30 trades$13.38M

Cluster activity · 60d

  1. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  2. BUYMTDRMatador Resources CoNov 5 – Nov 98 insiders$625K
  3. SELLFERGFerguson Enterprises Inc. /DE/Oct 12 – Oct 167 insiders$7.38M
  4. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  5. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M
  6. SELLIBEXIBEX LtdSep 14 – Sep 166 insiders$2.01M
  7. SELLARQQArqit Quantum Inc.Oct 2 – Oct 136 insiders$369K
  8. BUYBBTBeacon Financial CorpOct 26 – Oct 306 insiders$274K

Form 4 transactions

21,588 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
23
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$307K
3,400 sh
Jun 11, 2026
Page 243 of 540
← PrevNext →
Jun 15, 2026
traded Jun 11, 2026
+4d
SEC Form 4

Evidence

23
RA
Rohrstock AriehPresident, Gilat Peru
GILTGILAT SATELLITE NETWORKS LTD
Open-market sale · 10b5-1 plan
SELL$268K
17.6K sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

23
Bhatt BaijuDirector
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$708K
8,013 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

23
AY
Agiri Oluwagbemileke YusufCFO
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$88K
63.0K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

23
VS
Verma ShivChief Financial Officer
HOODRobinhood Markets, Inc.
Open-market sale · 10b5-1 plan
SELL$394K
3,984 sh
Jun 15, 2026Jun 15, 2026
traded Jun 15, 2026
+0dSEC Form 4

Evidence

22
VC
Voss Capital, LP10% Owner
PARPAR TECHNOLOGY CORP
Open-market purchase
BUY$25K
1,714 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

22
VC
Voss Capital, LP10% Owner
PARPAR TECHNOLOGY CORP
Open-market purchase
BUY$2,082
139 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

22
CD
Carr DouglasSVP Finance & Operations
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$3,692
1,654 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

22
RG
Russotti GregorySee Remarks
IPSCCentury Therapeutics, Inc.
Open-market sale
SELL$5,767
2,584 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

22
VC
Voss Capital, LP10% Owner
PARPAR TECHNOLOGY CORP
Open-market purchase
BUY$7,833
523 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

22
VC
Voss Capital, LP10% Owner
PARPAR TECHNOLOGY CORP
Open-market purchase
BUY$8,357
558 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

22
FJ
Flinn JosephDirector
HUTHut 8 Corp.
Open-market sale
SELL$956
8 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

21
FL
Feldmann Cynthia LDirector
UFPTUFP TECHNOLOGIES INC
Open-market sale
SELL$24K
100 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

21
ME
Makov EfratDirector
CRNTCERAGON NETWORKS LTD
Open-market sale
SELL$15K
5,000 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

21
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$272K
1,685 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

19
WS
Wallace SallyEVP, Chief Operating Officer
DRSLeonardo DRS, Inc.
Open-market sale · 10b5-1 plan
SELL$65K
1,300 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

19
BD
Bloom Paul DDirector, CEO
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$50K
35.2K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
GD
Gendenjamts DavaajargalVP Acctg and Treasurer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$6,118
4,293 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
KM
Krupka Devin MController, PAO
BANDBandwidth Inc.
Open-market sale · 10b5-1 plan
SELL$30K
456 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

16
BT
Bowron Kimberly TChief of Staff
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
15.5K sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

15
RD
Rigler DonPrincipal Accounting Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$24K
150 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

14
GS
Glaser ShelaghCFO
SNPSSYNOPSYS INC
Open-market sale · 10b5-1 plan
SELL$1.53M
3,394 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

14
LE
Lentell EricChief Legal & Strategy Officer
ACHRArcher Aviation Inc.
Open-market sale
SELL$19K
3,754 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

13
SA
Shafer AndrewChief Mktg Cust & Brnd Officer
GEVOGevo, Inc.
Open-market sale · 10b5-1 plan
SELL$13K
9,443 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$49K
300 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$16K
101 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
199 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
EM
Eaton Timothy MathiasChief Financial Officer
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$25K
160 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

11
PE
Pickering EvanGeneral Counsel
APPFAPPFOLIO INC
Open-market sale · 10b5-1 plan
SELL$31K
200 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

5
NW
Newton Charles W.Director
KROSKeros Therapeutics, Inc.
Open-market sale · 10b5-1 plan
SELL$5,522
550 sh
Jun 11, 2026Jun 15, 2026
traded Jun 11, 2026
+4dSEC Form 4

Evidence

0
CM
Cook MeredithSR. VP, GENERAL COUNSEL & SEC.
ANIPANI PHARMACEUTICALS INC
Open-market sale · 10b5-1 plan
SELL$41K
500 sh
Jun 12, 2026Jun 15, 2026
traded Jun 12, 2026
+3dSEC Form 4

Evidence

57
GD
Gray Steven DDirector
INRINFINITY NATURAL RESOURCES, INC.
Open-market purchase
BUY$320K
25.0K sh
Jun 12, 2026Jun 12, 2026
traded Jun 12, 2026
+0dSEC Form 4

Evidence

54
RA
Ross AndrewPortfolio Manager
ACLOXAristotle Pacific Enhanced CLO Income Fund
Open-market purchase
BUY$150K
5,871 sh
May 14, 2026Jun 12, 2026
traded May 14, 2026
+29dSEC Form 4

Evidence

53
SA
Still AshleyDirector
DASHDoorDash, Inc.
Open-market sale
SELL$179K
1,164 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

51
MB
Meadows BenjaminChief Commercial Officer
QTRXQuanterix Corp
Open-market purchase
BUY$9,695
3,500 sh
May 12, 2026Jun 12, 2026
traded May 12, 2026
+31dSEC Form 4

Evidence

42
LL
Lamattina John LDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$857K
3,405 sh
Jun 10, 2026Jun 12, 2026
traded Jun 10, 2026
+2dSEC Form 4

Evidence

41
AJ
Aryeh JasonDirector
LGNDLIGAND PHARMACEUTICALS INC
Open-market sale
SELL$1.13M
4,500 sh
Jun 11, 2026Jun 12, 2026
traded Jun 11, 2026
+1dSEC Form 4

Evidence